# Thymus Transplantation in DiGeorge Syndrome #668

> **NCT00576407** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma Switzerland GmbH** · enrollment: 26 (actual)

## Conditions studied

- DiGeorge Syndrome
- Complete Typical DiGeorge Anomaly

## Interventions

- **BIOLOGICAL:** Cultured Thymus Tissue for Implantation (CTTI)

## Key facts

- **NCT ID:** NCT00576407
- **Lead sponsor:** Sumitomo Pharma Switzerland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-10
- **Primary completion:** 2009-04
- **Final completion:** 2017-12-31
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576407, "Thymus Transplantation in DiGeorge Syndrome #668". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00576407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*